Squamous cell carcinoma of the anal canal: A review of the aetiology, presentation, staging, prognosis and methods available for treatment

Sexual Health

Volumn 9, Issue 6, 2012, Pages 593-609

  Szmulowicz, Ursula M ^a   Wu, James S ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

abdominoperineal resection; chemotherapy; dissection; human papillomavirus; lymph nodes; radiation.

Indexed keywords

CAPECITABINE; CETUXIMAB; CISPLATIN; FLUOROURACIL; MITOMYCIN C; OXALIPLATIN;

ANAL CANAL; ANUS CARCINOMA; ANUS SURGERY; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PREVENTION; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SCINTISCANNING; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; DIGITAL RECTAL EXAMINATION; DISEASE SURVEILLANCE; EMBRYO DEVELOPMENT; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; INTENSITY MODULATED RADIATION THERAPY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; META ANALYSIS; METASTASIS; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PAPILLOMAVIRUS INFECTION; POSITRON EMISSION TOMOGRAPHY; RADIATION DOSE; RECTUM ABDOMINOPERINEAL RESECTION; RECURRENCE RISK; SENTINEL LYMPH NODE BIOPSY; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME; TREATMENT FAILURE; VIRUS CARCINOGENESIS; WART VIRUS;

ADULT; ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; FEMALE; HOMOSEXUALITY, MALE; HUMANS; INCIDENCE; MALE; MASS SCREENING; NEOPLASM STAGING; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; RISK-TAKING; WORLD HEALTH;

EID: 84870466923     PISSN: 14485028     EISSN: 14498987     Source Type: Journal    
DOI: 10.1071/SH12010     Document Type: Article

References (110)

1. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011; 61(4): 212-36. doi:10.3322/caac.20121
2. Nigro ND. An evaluation of combined therapy for squamous cell cancer of the anal canal. Dis Colon Rectum 1984; 27(12): 763-6. doi:10.1007/BF02553933
3. Williams GR, Talbot IC. Anal carcinoma - a histological review. Histopathology 1994; 25(6): 507-16. doi:10.1111/j.1365-2559.1994. tb01370.x
4. Dougherty BG, Evans HL. Carcinoma of the anal canal: a study of 79 cases. Am J Clin Pathol 1985; 83(2): 159-64.
5. Singh R, Nime F, Mittelman A. Malignant epithelial tumors of the anal canal. Cancer 1981; 48(2): 411-5. doi:10.1002/1097-0142 (19810715)48:2<411:: AID-CNCR2820480232>3.0.CO;2-Z
6. Shia J. An update on tumors of the anal canal. Arch Pathol Lab Med 2010; 134(11): 1601-11.
7. Surveillance Epidemiology and End Results (SEER). SEER stat fact sheets: anal cancer. Bethesda: SEER; 2011. Available online at: http://seer.cancer.gov/ statfacts/html/anus.html [verified September 2011].
8. Pokorny WJ, Rothenberg SS, Brandt ML. Growth and development. In O'Leary JP, Capote LR, editors. The physiologic basis of surgery, 2nd ed. Philadelphia: Lippincott, Williams, & Wilkins; 1996. p. 61-66.
9. Moore K, Persaud T. The developing human: clinically oriented embryology, 8th ed. Philadelphia: Saunders; 2007.
10. Penington EC, Hutson JM. The cloacal plate: the missing link in anorectal and urogenital development. BJU Int 2002; 89: 726-32. doi:10.1046/j.1464-410X. 2002.02655.x
11. Zhang T, Zhang HL, Wang J, Tang XB, Jia HM, Bai YZ, et al. Normal development of hindgut and anorectum in human embryo. Int J Colorectal Dis 2011; 26(1): 109-16. doi:10.1007/s00384-010- 1034-2
12. Godlewski G, Prudhomme M. Embryology and anatomy of the anorectum. Basis of surgery. Surg Clin North Am 2000; 80(1): 319-43. doi:10.1016/S0039-6109(05) 70408-4
13. Akita K, Yamaguchi K, Sasaki C, Sato T. An embryological study of the anorectal system in mice. J Anat 2002; 201: 417-34.
14. Chawla AK, Willett CG. Squamous cell carcinoma of the anal canal and anal margin. Hematol Oncol Clin North Am 2001; 15(2): 321-344. doi:10.1016/S0889- 8588(05)70215-X
15. Oliver GC, Labow SB. Neoplasms of the anus. Surg Clin North Am 1994; 74(6): 1475-90.
16. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, editors. AJCC cancer staging manual, 7th ed. New York: Springer; 2010.
17. Klotz RG, Pamukcoglu T, Souilliard DH. Transitional cloacogenic carcinoma of the anal canal. Clinicopathologic study of three hundred seventy-three cases. Cancer 1967; 20(10): 1727-45. doi:10.1002/ 1097-0142(196710)20: 10<1727::AID-CNCR2820201024>3.0. CO;2-1
18. Stearns MW, Urmacher C, Sternberg SS, Woodruff J, Attiyeh F. Cancer of the anal canal. Curr Probl Cancer 1980; 4(12): 1-44. doi:10.1016/S0147-0272(80) 80015-8
19. Balamucki CJ, Zlotecki RA, Rout WR, Newlin HE, Morris CG, Kirwan JM, et al. Squamous cell carcinoma of the anal margin: the University of Florida experience. Am J Clin Oncol 2011; 34(4): 406-10. doi:10.1097/COC. 0b013e3181e9c0c0
20. Greenall MJ, Quan SH, DeCosse JJ. Epidermoid cancer of the anus. Br J Surg 1985; 72: S97-103. doi:10.1002/bjs.1800721350
21. Skibber J, Rodriguez-Bigas MA, Gordon PH. Surgical considerations in anal cancer. Surg Oncol Clin N Am 2004; 13(2): 321-38. doi:10.1016/j.soc.2003.12.006
22. Everett T, Bryant A, Griffin MF, Martin-Hirsch PP, Forbes CA, Jepson RG. Interventions targeted at women to encourage the uptake of cervical screening. Cochrane Database Syst Rev 2011; (5): 002834.
23. Cohen AM, Wong WD. Anal squamous cell cancer nodal metastases: prognostic significance and therapeutic considerations. Surg Oncol Clin N Am 1996; 5(1): 203-10.
24. De Nardi P, Carvello M, Canevari C, Passoni P, Staudacher C. Sentinel node biopsy in squamous-cell carcinoma of the anal canal. Ann Surg Oncol 2011; 18(2): 365-70. doi:10.1245/s10434-010-12 75-x
25. Buxton RW. Squamous cell anal carcinoma. AMA Arch Surg 1953; 67(6): 821-38. doi:10.1001/archsurg.1953.01260040834005
26. Clark J, Petrelli N, Herrera L, Mittelman A. Epidermoid carcinoma of the anal canal. Cancer 1986; 57(2): 400-6. doi:10.1002/1097-0142(19860115)57: 2<400::AID-CNCR28205702 37>3.0.CO;2-T
27. Kuehn PG, Eisenberg H, Reed JF. Epidermoid carcinoma of the perianal skin and anal canal. Cancer 1968; 22(5): 932-8. doi:10.1002/1097-0142(196811)22: 5<932::AID-CNCR2820220506 >3.0.CO;2-1
28. Palmer JG, Scholefield JH, Coates PJ, Shepherd NA, Jass JR, Crawford LV, et al. Anal cancer and human papillomaviruses. Dis Colon Rectum 1989; 32(12): 1016-22. doi:10.1007/BF02553 872
29. Williams GR, Lu QL, Love SB, Talbot IC, Northover JM. Properties of HPV-positive and HPV-negative anal carcinomas. J Pathol 1996; 180(4): 378-82. doi:10.1002/(SICI)1096-9896(199612)180:4<378:: AID-PATH697>3.0.CO;2-H
30. Frisch M, Glimelius B, van den Brule AJ, Wohlfahrt J, Meijer CJ, Walboomers JM, et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med 1997; 337(19): 1350-8. doi:10.1056/ NEJM199711063371904
31. Chaturvedi AK. Beyond cervical cancer: burden of other HPV-related cancers among men and women. J Adolesc Health 2010; 46(4): S20-6. doi:10.1016/j.jadohealth.2010.01.016
32. Oriel JD, Whimster IW. Carcinoma in situ associated with viruscontaining anal warts. Br J Dermatol 1971; 84(1): 71-3. doi:10.1111/ j.1365-2133.1971. tb14199.x
33. Parkin DM, Bray F. Chapter 2: the burden of HPV-related cancers. Vaccine 2006; 24: S11-25. doi:10.1016/j.vaccine.2006.05.111
34. Stanley M. Prophylactic HPV vaccines: prospects for eliminating anogenital cancer. Br J Cancer 2007; 96(9): 1320-3.
35. Muñoz N, Castellsague X, de Gonzalez AB, Gissmann L. Chapter 1: HPV in the etiology of human cancer. Vaccine 2006; 24: S1-10. doi:10.1016/j. vaccine.2006.05.115
36. Palefsky JM. Anal squamous intraepithelial lesions: relation to HIV and human papillomavirus infection. J Acquir Immune Defic Syndr 1999; 21: S42-8.
37. Lorenz HP, Wilson W, Leigh B, Crombleholme T, Schecter W. Squamous cell carcinoma of the anus and HIV infection. Dis Colon Rectum 1991; 34(4): 336-8. doi:10.1007/BF02050594
38. Khatri VP, Chopra S. Clinical presentation, imaging, and staging of anal cancer. Surg Oncol Clin N Am 2004; 13(2): 295-308. doi:10.1016/j.soc.2004.01.001
39. Fleshner PR, Chalasani S, Chang GJ, Levien DH, Hyman NH, Buie WD. (Standards Practice Task Force, American Society of Colon and Rectal Surgeons). Practice parameters for anal squamous neoplasms. Dis Colon Rectum 2008; 51(1): 2-9. doi:10.1007/s10350-007-9093-3
40. Buckwalter JA, Jurayj MN. Relationship of chronic anorectal disease to carcinoma. AMA Arch Surg 1957; 75(3): 352-361. doi:10.1001/ archsurg.1957. 01280150042005
41. Kline RJ, Spencer RJ. Harrison EG. Carcinoma associated with fistula-in-ano. Arch Surg 1964; 89: 989-94. doi:10.1001/archsurg. 1964.01320060057011
42. Milliken JC. Squamous carcinoma arising in an anal fistula. Br J Surg 1960; 48: 224. doi:10.1002/bjs.18004820831
43. Stearns MW Jr, Quan SH. Epidermoid carcinoma of the anorectum. Surg Gynecol Obstet 1970; 131(5): 953-7.
44. Myerson RJ, Karnell LH, Menck HR. The National Cancer Data Base report on carcinoma of the anus. Cancer 1997; 80(4): 805-15. doi:10.1002/(SICI)1097- 0142(19970815)80:4<805::AID-CNCR20> 3.0.CO;2-W
45. Mistrangelo M, Pelosi E, Bello M, Castellano I, Cassoni P, Ricardi U, et al. Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of inguinal node metastases in patients with anal cancer. Int J Radiat Oncol Biol Phys 2010; 77(1): 73-8. doi:10.1016/j.ijrobp.2009.04.020
46. Abbas A, Yang G, Fakih M. Management of anal cancer in 2010. Part 1: overview, screening, and diagnosis. Oncology 2010; 24(4): 364-9.
47. Nigro ND. Multidisciplinary management of cancer of the anus. Q World J Surg 1987; 11(4): 446-51. doi:10.1007/BF01655808
48. Hardcastle JD, Bussey HJ. Results of surgical treatment of squamous cell carcinoma of the anal canal and anal margin seen at St. Mark's Hospital 1928-66. Proc R Soc Med 1968; 61(6): 629-30.
49. Boman BM, Moertel CG, O'Connell MJ, Scott M, Weiland LH, Beart RW, et al. Carcinoma of the anal canal. A clinical and pathologic study of 188 cases. Cancer 1984; 54(1): 114-25. doi:10.1002/1097-0142 (19840701)54:1<114::AID- CNCR2820540124>3.0.CO;2-P
50. Frost DB, Richards PC, Montague ED, Giacco GG, Martin RG. Epidermoid cancer of the anorectum. Cancer 1984; 53(6): 1285-93. doi:10.1002/1097- 0142(19840315)53:6<1285::AID-CNC R2820530611>3.0.CO;2-N
51. Greenall MJ, Quan SH, Urmacher C, DeCosse JJ. Treatment of epidermoid carcinoma of the anal canal. Surg Gynecol Obstet 1985; 161(6): 509-17.
52. Nigro ND. The force of change in the management of squamous-cell cancer of the anal canal. Dis Colon Rectum 1991; 34(6): 482-6. doi:10.1007/BF02049934
53. Nigro ND, Vaitkevicius VK, Considine B. Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 1974; 17(3): 354-6. doi:10.1007/BF02586980
54. Nigro ND. An evaluation of combined therapy for squamous cell cancer of the anal canal. Dis Colon Rectum 1984; 27(12): 763-6. doi:10.1007/BF02553933
55. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin Lancet 1996; 348(9034): 1049-54. doi:10.1016/S0140-6736(96)03409-5
56. Bartelink H, Roelofsen F, Eschwege F, Rougier P, Bosset JF, Gonzalez DG, et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 1997; 15(5): 2040-9.
57. Flam M, John M, Pajak TF, Petrelli N, Myerson R, Doggett S, et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol 1996; 14(9): 2527-39.
58. Fraunholz I, Rabeneck D, Weiss C, Rodel C. Combined-modality treatment for anal cancer: current strategies and future directions. Strahlenther Onkol 2010; 186(7): 361-6. doi:10.1007/s00066-010- 2162-x
59. Chiao EY, Giordano TP, Richardson P, El-Serag HB. Human immunodeficiency virus-associated squamous cell cancer of the anus: epidemiology and outcomes in the highly active antiretroviral therapy era. J Clin Oncol 2008; 26(3): 474-9. doi:10.1200/JCO. 2007.14.2810
60. Meyer J, Willett C, Czito B. Current and emerging treatment strategies for anal cancer. Curr Oncol Rep 2010; 12(3): 168-74. doi:10.1007/ s11912-010-0100-9
61. Zagar TM, Willett CG, Czito BG. Intensity-modulated radiation therapy for anal cancer: toxicity versus outcomes. Oncology 2010; 24(9): 815-823.
62. Czito BG, Pepek JM, Meyer JJ, Yoo S, Willett CG. Intensitymodulated radiation therapy for anal cancer. Oncology 2009; 23(12): 1082-9.
63. Saarilahti K, Arponen P, Vaalavirta L, Tenhunen M. The effect of intensity-modulated radiotherapy and high dose rate brachytherapy on acute and late radiotherapy-related adverse events following chemoradiotherapy of anal cancer. Radiother Oncol 2008; 87(3): 383-90. doi:10.1016/j.radonc.2008.04.011
64. Pepek JM, Willett CG, Wu QJ, Yoo S, Clough RW, Czito BG. Intensity-modulated radiation therapy for anal malignancies: a preliminary toxicity and disease outcomes analysis. Int J Radiat Oncol Biol Phys 2010; 78(5): 1413-9. doi:10.1016/j.ijrobp.2009. 09.046
65. Roohipour R, Patil S, Goodman KA, Minsky BD, Wong WD, Guillem JG, et al. Squamous-cell carcinoma of the anal canal: predictors of treatment outcome. Dis Colon Rectum 2008; 51(2): 147-53. doi:10.1007/s10350-007-9125-z
66. Nilsson PJ, Svensson C, Goldman S, Glimelius B. Salvage abdominoperineal resection in anal epidermoid cancer. Br J Surg 2002; 89(11): 1425-9. doi:10.1046/j.1365-2168.2002.02231.x
67. Schraut WH, Wang CH, Dawson PJ, Block GE. Depth of invasion, location, and size of cancer of the anus dictate operative treatment. Cancer 1983; 51(7): 1291-6. doi:10.1002/1097-0142(19830401) 51:7<1291::AID-CNCR2820510719>3.0. CO;2-R
68. Hu K, Minsky BD, Cohen AM, Kelsen DP, Guillem JG, Paty PP, et al. 30 Gy may be an adequate dose in patients with anal cancer treated with excisional biopsy followed by combined-modality therapy. J Surg Oncol 1999; 70(2): 71-7. doi:10.1002/(SICI)1096-9098(199 902)70:2<71::AID-JSO2>3.0.CO;2-Y
69. Ortholan C, Ramaioli A, Peiffert D, Lusinchi A, Romestaing P, Chauveinc L, et al. Anal canal carcinoma: early-stage tumors < or = 10 mm (T1 or Tis): therapeutic options and original pattern of local failure after radiotherapy. Int J Radiat Oncol Biol Phys 2005; 62(2): 479-85. doi:10.1016/j.ijrobp.2004.09. 060
70. Chorost MI, Weber TK, Lee RJ, Rodriguez-Bigas MA, Petrelli NJ. Sexual dysfunction, informed consent and multimodality therapy for rectal cancer. Am J Surg 2000; 179(4): 271-4. doi:10.1016/S0002- 9610(00)00327-5
71. Eby LS, Sullivan ES. Current concepts of local excision of epidermoid carcinoma of the anus. Dis Colon Rectum 1969; 12(5): 332-7. doi:10.1007/ BF02617742
72. Lindkaer Jensen S, Hagen K, Harling H, Shokouh-Amiri MH, Nielsen OV. Long-term prognosis after radical treatment for squamous-cell carcinoma of the anal canal and anal margin. Dis Colon Rectum 1988; 31(4): 273-8. doi:10.1007/BF02554359
73. Pintor MP, Northover JM, Nicholls RJ. Squamous cell carcinoma of the anus at one hospital from 1948 to 1984. Br J Surg 1989; 76(8): 806-10. doi:10.1002/bjs.1800760814
74. Hughes LL, Rich TA, Delclos L, Ajani JA, Martin RG. Radiotherapy for anal cancer: experience from 1979-1987. Int J Radiat Oncol Biol Phys 1989; 17(6): 1153-60. doi:10.1016/0360-3016(89)90520-8
75. Longo WE, Vernava AM, Wade TP, Coplin MA, Virgo KS, Johnson FE. Recurrent squamous cell carcinoma of the anal canal. Predictors of initial treatment failure and results of salvage therapy. Ann Surg 1994; 220(1): 40-9. doi:10.1097/00000658-199407000-00007
76. Martenson JA Jr, Gunderson LL. External radiation therapy without chemotherapy in the management of anal cancer. Cancer 1993; 71(5): 1736-40. doi:10.1002/1097-0142(19930301)71:5<1736::AID-CNC R2820710506>3.0.CO;2-F
77. Dobrowsky W. Radiotherapy of epidermoid anal canal cancer. Br J Radiol 1989; 62(733): 53-8. doi:10.1259/0007-1285-62-733-53
78. Eeson G, Foo M, Harrow S, McGregor G, Hay J. Outcomes of salvage surgery for epidermoid carcinoma of the anus following failed combined modality treatment. Am J Surg 2011; 201(5): 628-33. doi:10.1016/j.amjsurg.2011.01.015
79. Smith AJ, Whelan P, Cummings BJ, Stern HS. Management of persistent or locally recurrent epidermoid cancer of the anal canal with abdominoperineal resection. Acta Oncol 2001; 40(1): 34-6. doi:10.1080/028418601750071028
80. Mullen JT, Rodriguez-Bigas MA, Chang GJ, Barcenas CH, Crane CH, Skibber JM, et al. Results of surgical salvage after failed chemoradiation therapy for epidermoid carcinoma of the anal canal. Ann Surg Oncol 2007; 14(2): 478-83. doi:10.1245/s10434-006-92 21-7
81. Ellenhorn JD, Enker WE, Quan SH. Salvage abdominoperineal resection following combined chemotherapy and radiotherapy for epidermoid carcinoma of the anus. Ann Surg Oncol 1994; 1(2): 105-10. doi:10.1007/BF02303552
82. Schiller DE, Cummings BJ, Rai S, Le LW, Last L, Davey P, et al. Outcomes of salvage surgery for squamous cell carcinoma of the anal canal. Ann Surg Oncol 2007; 14(10): 2780-9. doi:10.1245/s10434- 007-9491-8
83. Akbari RP, Paty PB, Guillem JG, Weiser MR, Temple LK, Minsky BD, et al. Oncologic outcomes of salvage surgery for epidermoid carcinoma of the anus initially managed with combined modality therapy. Dis Colon Rectum 2004; 47(7): 1136-44. doi:10.1007/ s10350-004-0548-5
84. Renehan AG, Saunders MP, Schofield PF, O'Dwyer ST. Patterns of local disease failure and outcome after salvage surgery in patients with anal cancer. Br J Surg 2005; 92(5): 605-14. doi:10.1002/bjs.4908
85. Zelnick RS, Haas PA, Ajlouni M, Szilagyi E, Fox TA. Results of abdominoperineal resections for failures after combination chemotherapy and radiation therapy for anal canal cancers. Dis Colon Rectum 1992; 35(6): 574-7. doi:10.1007/BF02050538
86. Ajani JA, Winter KA, Gunderson LL, Pedersen J, Benson AB, Thomas CR, et al. Prognostic factors derived from a prospective database dictate clinical biology of anal cancer: the intergroup trial (RTOG 98-11). Cancer 2010; 116(17): 4007-13. doi:10.1002/cncr. 25188
87. Staib L, Gottwald T, Lehnert T, Ruf G, Sturm J, Becker HD, et al. Sphincter-saving treatment in epidermoid anal cancer: cooperative analysis of 142 patients in five German university surgical centers. Int J Colorectal Dis 2000; 15(5-6): 282-90.
88. Bonin SR, Pajak TF, Russell AH, Coia LR, Paris KJ, Flam MS, et al. Overexpression of p53 protein and outcome of patients treated with chemoradiation for carcinoma of the anal canal: a report of randomized trial RTOG 87-04. Radiation Therapy Oncology Group. Cancer 1999; 85(6): 1226-33. doi:10.1002/(SICI)1097-0142(19990315)85:6<1226 ::AID-CNCR3>3.0.CO;2-B
89. van der Wal BC, Cleffken BI, Gulec B, Kaufman HS, Choti MA. Results of salvage abdominoperineal resection for recurrent anal carcinoma following combined chemoradiation therapy. J Gastrointest Surg 2001; 5(4): 383-7. doi:10.1016/S1091-255X(01) 80066-4
90. Stewart D, Yan Y, Kodner IJ, Birnbaum E, Fleshman J, Myerson R, et al. Salvage surgery after failed chemoradiation for anal canal cancer: should the paradigm be changed for high-risk tumors? J Gastrointest Surg 2007; 11(12): 1744-51. doi:10.1007/s11605-007-0232-x
91. Mariani P, Ghanneme A, De la Rochefordiere A, Girodet J, Falcou MC, Salmon RJ. Abdominoperineal resection for anal cancer. Dis Colon Rectum 2008; 51(10): 1495-501. doi:10.1007/s10350-008- 9361-x
92. Ghouti L, Houvenaeghel G, Moutardier V, Giovannini M, Magnin V, Lelong B, et al. Salvage abdominoperineal resection after failure of conservative treatment in anal epidermoid cancer. Dis Colon Rectum 2005; 48(1): 16-22. doi:10.1007/s10350-004-0746-1
93. Papaconstantinou HT, Bullard KM, Rothenberger DA, Madoff RD. Salvage abdominoperineal resection after failed Nigro protocol: modest success, major morbidity. Colorectal Dis 2006; 8(2): 124-9. doi:10.1111/j.1463-1318.2005.00911. x
94. Allal AS, Laurencet FM, Reymond MA, Kurtz JM, Marti MC. Effectiveness of surgical salvage therapy for patients with locally uncontrolled anal carcinoma after sphincter-conserving treatment. Cancer 1999; 86(3): 405-9. doi:10.1002/(SICI)1097-0142(199908 01)86:3<405::AID-CNCR7>3.0.CO;2-Q
95. Pocard M, Tiret E, Nugent K, Dehni N, Parc R. Results of salvage abdominoperineal resection for anal cancer after radiotherapy. Dis Colon Rectum 1998; 41(12): 1488-93. doi:10.1007/BF02237294
96. Buchs NC, Allal AS, Morel P, Gervaz P. Prevention, chemoradiation and surgery for anal cancer. Expert Rev Anticancer Ther 2009; 9(4): 483-9. doi:10.1586/era.09.4
97. National Cancer Institute (NCI). Anal cancer treatment (PDQ). Bethesda: NCI; 2011. Available online at: http://www.cancer.gov/cancertopics/pdq/ treatment/anal/HealthProfessional/page6 [verified October 2011].
98. Papillon J, Montbarbon JF. Epidermoid carcinoma of the anal canal. A series of 276 cases. Dis Colon Rectum 1987; 30(5): 324-33. doi:10.1007/ BF02555448
99. Gerard JP, Chapet O, Samiei F, Morignat E, Isaac S, Paulin C, et al. Management of inguinal lymph node metastases in patients with carcinoma of the anal canal: experience in a series of 270 patients treated in Lyon and review of the literature. Cancer 2001; 92(1): 77-84. doi:10.1002/1097-0142(20010701)92: 1<77::AID-CNCR129 4>3.0.CO;2-P
100. Damin DC, Rosito MA, Schwartsmann G. Sentinel lymph node in carcinoma of the anal canal: a review. Eur J Surg Oncol 2006; 32(3): 247-52. doi:10.1016/j.ejso.2005.08.006
101. Shank B. Treatment of anal canal carcinoma. Cancer 1985; 55: 2156-62. doi:10.1002/1097-0142(19850501)55:9+<2156::AID-CN CR2820551419>3.0.CO;2-0
102. de Jong JS, Beukema JC, van Dam GM, Slart R, Lemstra C, Wiggers T. Limited value of staging squamous cell carcinoma of the anal margin and canal using the sentinel lymph node procedure: a prospective study with long-term follow-up. Ann Surg Oncol 2010; 17(10): 2656-62. doi:10.1245/s10434-010-1063-7
103. Glynne-Jones R, Northover JM, Cervantes A. ESMO Guidelines Working Group. Anal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010; 21: v87-92. doi:10.1093/annonc/mdq171
104. Wade DS, Herrera L, Castillo NB, Petrelli NJ. Metastases to the lymph nodes in epidermoid carcinoma of the anal canal studied by a clearing technique. Surg Gynecol Obstet 1989; 169(3): 238-42.
105. Rousseau DL, Thomas CR, Petrelli NJ, Kahlenberg MS. Squamous cell carcinoma of the anal canal. Surg Oncol 2005; 14(3): 121-32. doi:10.1016/j.suronc.2005.07.002
106. Licitra L, Spinazze S, Doci R, Evans TR, Tanum G, Ducreux M. Cancer of the anal region. Crit Rev Oncol Hematol 2002; 43(1): 77-92. doi:10.1016/S1040- 8428(01)00193-7
107. Tokar M, Bobilev D, Zalmanov S, Geffen DB, Walfisch S. Combined multimodal approach to the treatment of metastatic anal carcinoma: report of a case and review of the literature. Onkologie 2006; 29(1-2): 30-2. doi:10.1159/000089798
108. Darragh TM, Winkler B. Anal cancer and cervical cancer screening: key differences. Cancer Cytopathol 2011; 119(1): 5-19. doi:10.1002/cncy.20126
109. Chin-Hong PV, Palefsky JM. Natural history and clinical management of anal human papillomavirus disease in men and women infected with human immunodeficiency virus. Clin Infect Dis 2002; 35(9): 1127-34. doi:10.1086/344057
110. Gillison ML, Chaturvedi AK, Lowy DR. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer 2008; 113(S10): 3036-46. doi:10.1002/cncr. 23764